APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pneumococcal Bacteria Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pneumococcal Bacteria Vaccine Market Analysis and Forecast 2026-2032

Report ID 17402675022 January 2026194 pages

Choose your research edition.

Industry ResearchPneumococcal Bacteria Vaccine Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Pneumococcal Bacteria Vaccine Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Pneumococcal Bacteria Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pneumococcal Bacteria Vaccine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Pneumococcal Bacteria Vaccine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Pneumococcal Bacteria Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pneumococcal Bacteria Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pneumococcal Bacteria Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pneumococcal Bacteria Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pneumococcal Bacteria Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Pneumococcal Bacteria Vaccine include Sanofi, Merck, Pfizer, GSK, Walvax and Sinopharm, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pneumococcal Bacteria Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pneumococcal Bacteria Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Pneumococcal Bacteria Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pneumococcal Bacteria Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pneumococcal Bacteria Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pneumococcal Bacteria Vaccine sales, projected growth trends, production technology, application and end-user industry.

Pneumococcal Bacteria Vaccine Segment by Company

Sanofi

Merck

Pfizer

GSK

Walvax

Sinopharm

Pneumococcal Bacteria Vaccine Segment by Type

PPSV 23

PCV 13

PCV 10

Pneumococcal Bacteria Vaccine Segment by Application

Infant

Children

Adult

Pneumococcal Bacteria Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pneumococcal Bacteria Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pneumococcal Bacteria Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pneumococcal Bacteria Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pneumococcal Bacteria Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pneumococcal Bacteria Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pneumococcal Bacteria Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pneumococcal Bacteria Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. PPSV 23 Major Manufacturers Table 3. PCV 13 Major Manufacturers Table 4. PCV 10 Major Manufacturers Table 5. Global Pneumococcal Bacteria Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Infant Major Manufacturers Table 7. Children Major Manufacturers Table 8. Adult Major Manufacturers Table 9. Pneumococcal Bacteria Vaccine Industry Trends Table 10. Pneumococcal Bacteria Vaccine Industry Drivers Table 11. Pneumococcal Bacteria Vaccine Industry Opportunities and Challenges Table 12. Pneumococcal Bacteria Vaccine Industry Restraints Table 13. Global Pneumococcal Bacteria Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Pneumococcal Bacteria Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Pneumococcal Bacteria Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Region (2021-2026) Table 17. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Region (2027-2032) Table 18. Global Pneumococcal Bacteria Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Doses) Table 19. Global Pneumococcal Bacteria Vaccine Sales by Region (2021-2026) & (K Doses) Table 20. Global Pneumococcal Bacteria Vaccine Sales by Region (2027-2032) & (K Doses) Table 21. Global Pneumococcal Bacteria Vaccine Sales Market Share by Region (2021-2026) Table 22. Global Pneumococcal Bacteria Vaccine Sales Market Share by Region (2027-2032) Table 23. Global Pneumococcal Bacteria Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Pneumococcal Bacteria Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Pneumococcal Bacteria Vaccine Sales Market Share by Manufacturers (2021-2026) Table 27. Global Pneumococcal Bacteria Vaccine Sales Price (US$/Dose) of Manufacturers (2021-2026) Table 28. Global Pneumococcal Bacteria Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Pneumococcal Bacteria Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Pneumococcal Bacteria Vaccine Manufacturers, Product Type & Application Table 31. Global Pneumococcal Bacteria Vaccine Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Pneumococcal Bacteria Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Pneumococcal Bacteria Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Pneumococcal Bacteria Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Pneumococcal Bacteria Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2021-2026) Table 38. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2027-2032) Table 39. Global Pneumococcal Bacteria Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Doses) Table 40. Global Pneumococcal Bacteria Vaccine Sales by Type (2021-2026) & (K Doses) Table 41. Global Pneumococcal Bacteria Vaccine Sales by Type (2027-2032) & (K Doses) Table 42. Global Pneumococcal Bacteria Vaccine Sales Market Share by Type (2021-2026) Table 43. Global Pneumococcal Bacteria Vaccine Sales Market Share by Type (2027-2032) Table 44. Global Pneumococcal Bacteria Vaccine Price by Type (2021-2026) & (US$/Dose) Table 45. Global Pneumococcal Bacteria Vaccine Price by Type (2027-2032) & (US$/Dose) Table 46. Global Pneumococcal Bacteria Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Pneumococcal Bacteria Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Pneumococcal Bacteria Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2021-2026) Table 50. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2027-2032) Table 51. Global Pneumococcal Bacteria Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Doses) Table 52. Global Pneumococcal Bacteria Vaccine Sales by Application (2021-2026) & (K Doses) Table 53. Global Pneumococcal Bacteria Vaccine Sales by Application (2027-2032) & (K Doses) Table 54. Global Pneumococcal Bacteria Vaccine Sales Market Share by Application (2021-2026) Table 55. Global Pneumococcal Bacteria Vaccine Sales Market Share by Application (2027-2032) Table 56. Global Pneumococcal Bacteria Vaccine Price by Application (2021-2026) & (US$/Dose) Table 57. Global Pneumococcal Bacteria Vaccine Price by Application (2027-2032) & (US$/Dose) Table 58. Sanofi Company Information Table 59. Sanofi Business Overview Table 60. Sanofi Pneumococcal Bacteria Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 61. Sanofi Pneumococcal Bacteria Vaccine Product Portfolio Table 62. Sanofi Recent Development Table 63. Merck Company Information Table 64. Merck Business Overview Table 65. Merck Pneumococcal Bacteria Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 66. Merck Pneumococcal Bacteria Vaccine Product Portfolio Table 67. Merck Recent Development Table 68. Pfizer Company Information Table 69. Pfizer Business Overview Table 70. Pfizer Pneumococcal Bacteria Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 71. Pfizer Pneumococcal Bacteria Vaccine Product Portfolio Table 72. Pfizer Recent Development Table 73. GSK Company Information Table 74. GSK Business Overview Table 75. GSK Pneumococcal Bacteria Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 76. GSK Pneumococcal Bacteria Vaccine Product Portfolio Table 77. GSK Recent Development Table 78. Walvax Company Information Table 79. Walvax Business Overview Table 80. Walvax Pneumococcal Bacteria Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 81. Walvax Pneumococcal Bacteria Vaccine Product Portfolio Table 82. Walvax Recent Development Table 83. Sinopharm Company Information Table 84. Sinopharm Business Overview Table 85. Sinopharm Pneumococcal Bacteria Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 86. Sinopharm Pneumococcal Bacteria Vaccine Product Portfolio Table 87. Sinopharm Recent Development Table 88. North America Pneumococcal Bacteria Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 89. North America Pneumococcal Bacteria Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 90. North America Pneumococcal Bacteria Vaccine Sales by Type (2021-2026) & (K Doses) Table 91. North America Pneumococcal Bacteria Vaccine Sales by Type (2027-2032) & (K Doses) Table 92. North America Pneumococcal Bacteria Vaccine Sales Price by Type (2021-2026) & (US$/Dose) Table 93. North America Pneumococcal Bacteria Vaccine Sales Price by Type (2027-2032) & (US$/Dose) Table 94. North America Pneumococcal Bacteria Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 95. North America Pneumococcal Bacteria Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 96. North America Pneumococcal Bacteria Vaccine Sales by Application (2021-2026) & (K Doses) Table 97. North America Pneumococcal Bacteria Vaccine Sales by Application (2027-2032) & (K Doses) Table 98. North America Pneumococcal Bacteria Vaccine Sales Price by Application (2021-2026) & (US$/Dose) Table 99. North America Pneumococcal Bacteria Vaccine Sales Price by Application (2027-2032) & (US$/Dose) Table 100. North America Pneumococcal Bacteria Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Pneumococcal Bacteria Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 102. North America Pneumococcal Bacteria Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 103. North America Pneumococcal Bacteria Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Doses) Table 104. North America Pneumococcal Bacteria Vaccine Sales by Country (2021-2026) & (K Doses) Table 105. North America Pneumococcal Bacteria Vaccine Sales by Country (2027-2032) & (K Doses) Table 106. North America Pneumococcal Bacteria Vaccine Sales Price by Country (2021-2026) & (US$/Dose) Table 107. North America Pneumococcal Bacteria Vaccine Sales Price by Country (2027-2032) & (US$/Dose) Table 108. United States Pneumococcal Bacteria Vaccine Revenue (2021-2032) & (US$ Million) Table 109. Canada Pneumococcal Bacteria Vaccine Revenue (2021-2032) & (US$ Million) Table 110. Europe Pneumococcal Bacteria Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 111. Europe Pneumococcal Bacteria Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 112. Europe Pneumococcal Bacteria Vaccine Sales by Type (2021-2026) & (K Doses) Table 113. Europe Pneumococcal Bacteria Vaccine Sales by Type (2027-2032) & (K Doses) Table 114. Europe Pneumococcal Bacteria Vaccine Sales Price by Type (2021-2026) & (US$/Dose) Table 115. Europe Pneumococcal Bacteria Vaccine Sales Price by Type (2027-2032) & (US$/Dose) Table 116. Europe Pneumococcal Bacteria Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 117. Europe Pneumococcal Bacteria Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 118. Europe Pneumococcal Bacteria Vaccine Sales by Application (2021-2026) & (K Doses) Table 119. Europe Pneumococcal Bacteria Vaccine Sales by Application (2027-2032) & (K Doses) Table 120. Europe Pneumococcal Bacteria Vaccine Sales Price by Application (2021-2026) & (US$/Dose) Table 121. Europe Pneumococcal Bacteria Vaccine Sales Price by Application (2027-2032) & (US$/Dose) Table 122. Europe Pneumococcal Bacteria Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Pneumococcal Bacteria Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 124. Europe Pneumococcal Bacteria Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 125. Europe Pneumococcal Bacteria Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Doses) Table 126. Europe Pneumococcal Bacteria Vaccine Sales by Country (2021-2026) & (K Doses) Table 127. Europe Pneumococcal Bacteria Vaccine Sales by Country (2027-2032) & (K Doses) Table 128. Europe Pneumococcal Bacteria Vaccine Sales Price by Country (2021-2026) & (US$/Dose) Table 129. Europe Pneumococcal Bacteria Vaccine Sales Price by Country (2027-2032) & (US$/Dose) Table 130. Germany Pneumococcal Bacteria Vaccine Revenue (2021-2032) & (US$ Million) Table 131. France Pneumococcal Bacteria Vaccine Revenue (2021-2032) & (US$ Million) Table 132. U.K. Pneumococcal Bacteria Vaccine Revenue (2021-2032) & (US$ Million) Table 133. Italy Pneumococcal Bacteria Vaccine Revenue (2021-2032) & (US$ Million) Table 134. Netherlands Pneumococcal Bacteria Vaccine Revenue (2021-2032) & (US$ Million) Table 135. Nordic Countries Pneumococcal Bacteria Vaccine Revenue (2021-2032) & (US$ Million) Table 136. China Pneumococcal Bacteria Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 137. China Pneumococcal Bacteria Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 138. China Pneumococcal Bacteria Vaccine Sales by Type (2021-2026) & (K Doses) Table 139. China Pneumococcal Bacteria Vaccine Sales by Type (2027-2032) & (K Doses) Table 140. China Pneumococcal Bacteria Vaccine Sales Price by Type (2021-2026) & (US$/Dose) Table 141. China Pneumococcal Bacteria Vaccine Sales Price by Type (2027-2032) & (US$/Dose) Table 142. China Pneumococcal Bacteria Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 143. China Pneumococcal Bacteria Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 144. China Pneumococcal Bacteria Vaccine Sales by Application (2021-2026) & (K Doses) Table 145. China Pneumococcal Bacteria Vaccine Sales by Application (2027-2032) & (K Doses) Table 146. China Pneumococcal Bacteria Vaccine Sales Price by Application (2021-2026) & (US$/Dose) Table 147. China Pneumococcal Bacteria Vaccine Sales Price by Application (2027-2032) & (US$/Dose) Table 148. Asia Pneumococcal Bacteria Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 149. Asia Pneumococcal Bacteria Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 150. Asia Pneumococcal Bacteria Vaccine Sales by Type (2021-2026) & (K Doses) Table 151. Asia Pneumococcal Bacteria Vaccine Sales by Type (2027-2032) & (K Doses) Table 152. Asia Pneumococcal Bacteria Vaccine Sales Price by Type (2021-2026) & (US$/Dose) Table 153. Asia Pneumococcal Bacteria Vaccine Sales Price by Type (2027-2032) & (US$/Dose) Table 154. Asia Pneumococcal Bacteria Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 155. Asia Pneumococcal Bacteria Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 156. Asia Pneumococcal Bacteria Vaccine Sales by Application (2021-2026) & (K Doses) Table 157. Asia Pneumococcal Bacteria Vaccine Sales by Application (2027-2032) & (K Doses) Table 158. Asia Pneumococcal Bacteria Vaccine Sales Price by Application (2021-2026) & (US$/Dose) Table 159. Asia Pneumococcal Bacteria Vaccine Sales Price by Application (2027-2032) & (US$/Dose) Table 160. Asia Pneumococcal Bacteria Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 161. Asia Pneumococcal Bacteria Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 162. Asia Pneumococcal Bacteria Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 163. Asia Pneumococcal Bacteria Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Doses) Table 164. Asia Pneumococcal Bacteria Vaccine Sales by Country (2021-2026) & (K Doses) Table 165. Asia Pneumococcal Bacteria Vaccine Sales by Country (2027-2032) & (K Doses) Table 166. Asia Pneumococcal Bacteria Vaccine Sales Price by Country (2021-2026) & (US$/Dose) Table 167. Asia Pneumococcal Bacteria Vaccine Sales Price by Country (2027-2032) & (US$/Dose) Table 168. Japan Pneumococcal Bacteria Vaccine Revenue (2021-2032) & (US$ Million) Table 169. South Korea Pneumococcal Bacteria Vaccine Revenue (2021-2032) & (US$ Million) Table 170. India Pneumococcal Bacteria Vaccine Revenue (2021-2032) & (US$ Million) Table 171. Australia Pneumococcal Bacteria Vaccine Revenue (2021-2032) & (US$ Million) Table 172. China Taiwan Pneumococcal Bacteria Vaccine Revenue (2021-2032) & (US$ Million) Table 173. Southeast Asia Pneumococcal Bacteria Vaccine Revenue (2021-2032) & (US$ Million) Table 174. SAMEA Pneumococcal Bacteria Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 175. SAMEA Pneumococcal Bacteria Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 176. SAMEA Pneumococcal Bacteria Vaccine Sales by Type (2021-2026) & (K Doses) Table 177. SAMEA Pneumococcal Bacteria Vaccine Sales by Type (2027-2032) & (K Doses) Table 178. SAMEA Pneumococcal Bacteria Vaccine Sales Price by Type (2021-2026) & (US$/Dose) Table 179. SAMEA Pneumococcal Bacteria Vaccine Sales Price by Type (2027-2032) & (US$/Dose) Table 180. SAMEA Pneumococcal Bacteria Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 181. SAMEA Pneumococcal Bacteria Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 182. SAMEA Pneumococcal Bacteria Vaccine Sales by Application (2021-2026) & (K Doses) Table 183. SAMEA Pneumococcal Bacteria Vaccine Sales by Application (2027-2032) & (K Doses) Table 184. SAMEA Pneumococcal Bacteria Vaccine Sales Price by Application (2021-2026) & (US$/Dose) Table 185. SAMEA Pneumococcal Bacteria Vaccine Sales Price by Application (2027-2032) & (US$/Dose) Table 186. SAMEA Pneumococcal Bacteria Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 187. SAMEA Pneumococcal Bacteria Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 188. SAMEA Pneumococcal Bacteria Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 189. SAMEA Pneumococcal Bacteria Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Doses) Table 190. SAMEA Pneumococcal Bacteria Vaccine Sales by Country (2021-2026) & (K Doses) Table 191. SAMEA Pneumococcal Bacteria Vaccine Sales by Country (2027-2032) & (K Doses) Table 192. SAMEA Pneumococcal Bacteria Vaccine Sales Price by Country (2021-2026) & (US$/Dose) Table 193. SAMEA Pneumococcal Bacteria Vaccine Sales Price by Country (2027-2032) & (US$/Dose) Table 194. Brazil Pneumococcal Bacteria Vaccine Revenue (2021-2032) & (US$ Million) Table 195. Argentina Pneumococcal Bacteria Vaccine Revenue (2021-2032) & (US$ Million) Table 196. Chile Pneumococcal Bacteria Vaccine Revenue (2021-2032) & (US$ Million) Table 197. Colombia Pneumococcal Bacteria Vaccine Revenue (2021-2032) & (US$ Million) Table 198. Peru Pneumococcal Bacteria Vaccine Revenue (2021-2032) & (US$ Million) Table 199. Saudi Arabia Pneumococcal Bacteria Vaccine Revenue (2021-2032) & (US$ Million) Table 200. Israel Pneumococcal Bacteria Vaccine Revenue (2021-2032) & (US$ Million) Table 201. UAE Pneumococcal Bacteria Vaccine Revenue (2021-2032) & (US$ Million) Table 202. Turkey Pneumococcal Bacteria Vaccine Revenue (2021-2032) & (US$ Million) Table 203. Iran Pneumococcal Bacteria Vaccine Revenue (2021-2032) & (US$ Million) Table 204. Egypt Pneumococcal Bacteria Vaccine Revenue (2021-2032) & (US$ Million) Table 205. Key Raw Materials Table 206. Raw Materials Key Suppliers Table 207. Pneumococcal Bacteria Vaccine Distributors List Table 208. Pneumococcal Bacteria Vaccine Customers List Table 209. Research Programs/Design for This Report Table 210. Authors List of This Report Table 211. Secondary Sources Table 212. Primary Sources List of Figures Figure 1. Pneumococcal Bacteria Vaccine Image Figure 2. Global Pneumococcal Bacteria Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pneumococcal Bacteria Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. PPSV 23 Image Figure 5. PCV 13 Image Figure 6. PCV 10 Image Figure 7. Global Pneumococcal Bacteria Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Pneumococcal Bacteria Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 9. Infant Image Figure 10. Children Image Figure 11. Adult Image Figure 12. Global Pneumococcal Bacteria Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Pneumococcal Bacteria Vaccine Revenue (2021-2032) & (US$ Million) Figure 14. Global Pneumococcal Bacteria Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Region (2021-2032) Figure 17. Global Pneumococcal Bacteria Vaccine Sales (2021-2032) & (K Doses) Figure 18. Global Pneumococcal Bacteria Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Doses) Figure 19. Global Pneumococcal Bacteria Vaccine Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Pneumococcal Bacteria Vaccine Sales YoY (2021-2032) & (K Doses) Figure 21. Europe Pneumococcal Bacteria Vaccine Sales YoY (2021-2032) & (K Doses) Figure 22. China Pneumococcal Bacteria Vaccine Sales YoY (2021-2032) & (K Doses) Figure 23. Asia (Excluding China) Pneumococcal Bacteria Vaccine Sales YoY (2021-2032) & (K Doses) Figure 24. South America, Middle East and Africa Pneumococcal Bacteria Vaccine Sales YoY (2021-2032) & (K Doses) Figure 25. Global Pneumococcal Bacteria Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Pneumococcal Bacteria Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Pneumococcal Bacteria Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2021-2032) Figure 31. Global Pneumococcal Bacteria Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Doses) Figure 32. Global Pneumococcal Bacteria Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Pneumococcal Bacteria Vaccine Sales Market Share by Type (2021-2032) Figure 34. Global Pneumococcal Bacteria Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2021-2032) Figure 37. Global Pneumococcal Bacteria Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Doses) Figure 38. Global Pneumococcal Bacteria Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Pneumococcal Bacteria Vaccine Sales Market Share by Application (2021-2032) Figure 40. North America Pneumococcal Bacteria Vaccine Revenue Share by Type (2021-2032) Figure 41. North America Pneumococcal Bacteria Vaccine Sales Share by Type (2021-2032) Figure 42. North America Pneumococcal Bacteria Vaccine Revenue Share by Application (2021-2032) Figure 43. North America Pneumococcal Bacteria Vaccine Sales Share by Application (2021-2032) Figure 44. North America Pneumococcal Bacteria Vaccine Revenue Share by Country (2021-2032) Figure 45. North America Pneumococcal Bacteria Vaccine Sales Share by Country (2021-2032) Figure 46. Europe Pneumococcal Bacteria Vaccine Revenue Share by Type (2021-2032) Figure 47. Europe Pneumococcal Bacteria Vaccine Sales Share by Type (2021-2032) Figure 48. Europe Pneumococcal Bacteria Vaccine Revenue Share by Application (2021-2032) Figure 49. Europe Pneumococcal Bacteria Vaccine Sales Share by Application (2021-2032) Figure 50. Europe Pneumococcal Bacteria Vaccine Revenue Share by Country (2021-2032) Figure 51. Europe Pneumococcal Bacteria Vaccine Sales Share by Country (2021-2032) Figure 52. China Pneumococcal Bacteria Vaccine Revenue Share by Type (2021-2032) Figure 53. China Pneumococcal Bacteria Vaccine Sales Share by Type (2021-2032) Figure 54. China Pneumococcal Bacteria Vaccine Revenue Share by Application (2021-2032) Figure 55. China Pneumococcal Bacteria Vaccine Sales Share by Application (2021-2032) Figure 56. Asia Pneumococcal Bacteria Vaccine Revenue Share by Type (2021-2032) Figure 57. Asia Pneumococcal Bacteria Vaccine Sales Share by Type (2021-2032) Figure 58. Asia Pneumococcal Bacteria Vaccine Revenue Share by Application (2021-2032) Figure 59. Asia Pneumococcal Bacteria Vaccine Sales Share by Application (2021-2032) Figure 60. Asia Pneumococcal Bacteria Vaccine Revenue Share by Country (2021-2032) Figure 61. Asia Pneumococcal Bacteria Vaccine Sales Share by Country (2021-2032) Figure 62. SAMEA Pneumococcal Bacteria Vaccine Revenue Share by Type (2021-2032) Figure 63. SAMEA Pneumococcal Bacteria Vaccine Sales Share by Type (2021-2032) Figure 64. SAMEA Pneumococcal Bacteria Vaccine Revenue Share by Application (2021-2032) Figure 65. SAMEA Pneumococcal Bacteria Vaccine Sales Share by Application (2021-2032) Figure 66. SAMEA Pneumococcal Bacteria Vaccine Revenue Share by Country (2021-2032) Figure 67. SAMEA Pneumococcal Bacteria Vaccine Sales Share by Country (2021-2032) Figure 68. Pneumococcal Bacteria Vaccine Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Pneumococcal Bacteria Vaccine Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • PPSV 23
  • PCV 13
  • PCV 10
Applications
  • Infant
  • Children
  • Adult
Companies covered
  • Sanofi
  • Merck
  • Pfizer
  • GSK
  • Walvax
  • Sinopharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pneumococcal Bacteria Vaccine Market by Type
  3. 1.2.1 Global Pneumococcal Bacteria Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 PPSV 23
  5. 1.2.3 PCV 13
  6. 1.2.4 PCV 10
  7. 1.3 Pneumococcal Bacteria Vaccine Market by Application
  8. 1.3.1 Global Pneumococcal Bacteria Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Infant
  10. 1.3.3 Children
  11. 1.3.4 Adult
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Pneumococcal Bacteria Vaccine Market Dynamics
  1. 2.1 Pneumococcal Bacteria Vaccine Industry Trends
  2. 2.2 Pneumococcal Bacteria Vaccine Industry Drivers
  3. 2.3 Pneumococcal Bacteria Vaccine Industry Opportunities and Challenges
  4. 2.4 Pneumococcal Bacteria Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pneumococcal Bacteria Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pneumococcal Bacteria Vaccine Revenue by Region
  3. 3.2.1 Global Pneumococcal Bacteria Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pneumococcal Bacteria Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Pneumococcal Bacteria Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Pneumococcal Bacteria Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pneumococcal Bacteria Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pneumococcal Bacteria Vaccine Sales by Region
  9. 3.4.1 Global Pneumococcal Bacteria Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pneumococcal Bacteria Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Pneumococcal Bacteria Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Pneumococcal Bacteria Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pneumococcal Bacteria Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Pneumococcal Bacteria Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pneumococcal Bacteria Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pneumococcal Bacteria Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pneumococcal Bacteria Vaccine Sales by Manufacturers
  6. 4.2.1 Global Pneumococcal Bacteria Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pneumococcal Bacteria Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pneumococcal Bacteria Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pneumococcal Bacteria Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pneumococcal Bacteria Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pneumococcal Bacteria Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pneumococcal Bacteria Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Pneumococcal Bacteria Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pneumococcal Bacteria Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Pneumococcal Bacteria Vaccine Tier 1, Tier 2, and Tier 3
5 Pneumococcal Bacteria Vaccine Market by Type
  1. 5.1 Global Pneumococcal Bacteria Vaccine Revenue by Type
  2. 5.1.1 Global Pneumococcal Bacteria Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pneumococcal Bacteria Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pneumococcal Bacteria Vaccine Sales by Type
  6. 5.2.1 Global Pneumococcal Bacteria Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pneumococcal Bacteria Vaccine Sales by Type (2021-2032) & (K Doses)
  8. 5.2.3 Global Pneumococcal Bacteria Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pneumococcal Bacteria Vaccine Price by Type
6 Pneumococcal Bacteria Vaccine Market by Application
  1. 6.1 Global Pneumococcal Bacteria Vaccine Revenue by Application
  2. 6.1.1 Global Pneumococcal Bacteria Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pneumococcal Bacteria Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pneumococcal Bacteria Vaccine Sales by Application
  6. 6.2.1 Global Pneumococcal Bacteria Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pneumococcal Bacteria Vaccine Sales by Application (2021-2032) & (K Doses)
  8. 6.2.3 Global Pneumococcal Bacteria Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pneumococcal Bacteria Vaccine Price by Application
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi Pneumococcal Bacteria Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Pneumococcal Bacteria Vaccine Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck Pneumococcal Bacteria Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck Pneumococcal Bacteria Vaccine Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 Pfizer
  14. 7.3.1 Pfizer Company Information
  15. 7.3.2 Pfizer Business Overview
  16. 7.3.3 Pfizer Pneumococcal Bacteria Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer Pneumococcal Bacteria Vaccine Product Portfolio
  18. 7.3.5 Pfizer Recent Developments
  19. 7.4 GSK
  20. 7.4.1 GSK Company Information
  21. 7.4.2 GSK Business Overview
  22. 7.4.3 GSK Pneumococcal Bacteria Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 GSK Pneumococcal Bacteria Vaccine Product Portfolio
  24. 7.4.5 GSK Recent Developments
  25. 7.5 Walvax
  26. 7.5.1 Walvax Company Information
  27. 7.5.2 Walvax Business Overview
  28. 7.5.3 Walvax Pneumococcal Bacteria Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Walvax Pneumococcal Bacteria Vaccine Product Portfolio
  30. 7.5.5 Walvax Recent Developments
  31. 7.6 Sinopharm
  32. 7.6.1 Sinopharm Company Information
  33. 7.6.2 Sinopharm Business Overview
  34. 7.6.3 Sinopharm Pneumococcal Bacteria Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Sinopharm Pneumococcal Bacteria Vaccine Product Portfolio
  36. 7.6.5 Sinopharm Recent Developments
8 North America
  1. 8.1 North America Pneumococcal Bacteria Vaccine Market Size by Type
  2. 8.1.1 North America Pneumococcal Bacteria Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Pneumococcal Bacteria Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Pneumococcal Bacteria Vaccine Price by Type (2021-2032)
  5. 8.2 North America Pneumococcal Bacteria Vaccine Market Size by Application
  6. 8.2.1 North America Pneumococcal Bacteria Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Pneumococcal Bacteria Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Pneumococcal Bacteria Vaccine Price by Application (2021-2032)
  9. 8.3 North America Pneumococcal Bacteria Vaccine Market Size by Country
  10. 8.3.1 North America Pneumococcal Bacteria Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pneumococcal Bacteria Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pneumococcal Bacteria Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Pneumococcal Bacteria Vaccine Market Size by Type
  2. 9.1.1 Europe Pneumococcal Bacteria Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pneumococcal Bacteria Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Pneumococcal Bacteria Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Pneumococcal Bacteria Vaccine Market Size by Application
  6. 9.2.1 Europe Pneumococcal Bacteria Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pneumococcal Bacteria Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Pneumococcal Bacteria Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Pneumococcal Bacteria Vaccine Market Size by Country
  10. 9.3.1 Europe Pneumococcal Bacteria Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pneumococcal Bacteria Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pneumococcal Bacteria Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Pneumococcal Bacteria Vaccine Market Size by Type
  2. 10.1.1 China Pneumococcal Bacteria Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Pneumococcal Bacteria Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Pneumococcal Bacteria Vaccine Price by Type (2021-2032)
  5. 10.2 China Pneumococcal Bacteria Vaccine Market Size by Application
  6. 10.2.1 China Pneumococcal Bacteria Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Pneumococcal Bacteria Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Pneumococcal Bacteria Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pneumococcal Bacteria Vaccine Market Size by Type
  2. 11.1.1 Asia Pneumococcal Bacteria Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pneumococcal Bacteria Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Pneumococcal Bacteria Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Pneumococcal Bacteria Vaccine Market Size by Application
  6. 11.2.1 Asia Pneumococcal Bacteria Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pneumococcal Bacteria Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Pneumococcal Bacteria Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Pneumococcal Bacteria Vaccine Market Size by Country
  10. 11.3.1 Asia Pneumococcal Bacteria Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pneumococcal Bacteria Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pneumococcal Bacteria Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pneumococcal Bacteria Vaccine Market Size by Type
  2. 12.1.1 SAMEA Pneumococcal Bacteria Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pneumococcal Bacteria Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pneumococcal Bacteria Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Pneumococcal Bacteria Vaccine Market Size by Application
  6. 12.2.1 SAMEA Pneumococcal Bacteria Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pneumococcal Bacteria Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pneumococcal Bacteria Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Pneumococcal Bacteria Vaccine Market Size by Country
  10. 12.3.1 SAMEA Pneumococcal Bacteria Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pneumococcal Bacteria Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pneumococcal Bacteria Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pneumococcal Bacteria Vaccine Value Chain Analysis
  2. 13.1.1 Pneumococcal Bacteria Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pneumococcal Bacteria Vaccine Production Mode & Process
  6. 13.2 Pneumococcal Bacteria Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pneumococcal Bacteria Vaccine Distributors
  9. 13.2.3 Pneumococcal Bacteria Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst